Skip to main content
. Author manuscript; available in PMC: 2017 Jul 16.
Published in final edited form as: Lancet Neurol. 2011 Jul;10(7):637–648. doi: 10.1016/S1474-4422(11)70106-5
JM: none declared.
GLM: none declared.
FB: received fees as consultant and/or speaker from Pfizer, Grünenthal, Lilly, MedUpdate, Glaxo, and for expert testimony for Jerini.
RB: received grants or research report from Pfizer, Genzyme, Grünenthal; is a member of the IMI “Europain” collaboration and industry members of this are: Astra Zenica, Pfizer, Esteve, UCB-Pharma, Sanofi Aventis, Grünenthal, Eli Lilly, Neuroscience technologies and Boehringer Ingelheim; received fees as consultant and/or speaker from Pfizer, Genzyme, Grünenthal, Mundipharma, Allergan, Sanofi Pasteur, Medtronic, Eisai, UCB BioSciences, Lilly, Boehringer Ingelheim, Astellas and Novartis.
CM: received fees as consultant and/or speaker from Pfizer, Bionorica, Allergan and Grünenthal.
WK: none declared.
JJvH: received fees as consultant and speaker from Medtronic, GSK and Novartis.